Goldman Sachs’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.1M | Buy |
|
|||||
|
2025
Q1 | $24.6M | Buy |
|
|||||
|
2024
Q4 | $24.9M | Sell |
|
|||||
|
2024
Q3 | $62.2M | Buy |
|
|||||
|
2024
Q2 | $44.4M | Buy |
|
|||||
|
2024
Q1 | $15.8M | Buy |
|
|||||
|
2023
Q4 | $4.64M | Buy |
|
|||||
|
2023
Q3 | $2.83M | Buy |
|
|||||
|
2023
Q2 | $999K | Sell |
|
|||||
|
2023
Q1 | $13.1M | Buy |
|
|||||
|
2022
Q4 | $4.17M | Buy |
|
|||||
|
2022
Q3 | $639K | Sell |
|
|||||
|
2022
Q2 | $819K | Buy |
|
|||||
|
2022
Q1 | $100K | Buy |
|